Metronidazole, nitrofurantoin, trimethoprim & others
also: metronidazole · nitrofurantoin · trimethoprim · co-trimoxazole · clindamycin
Overview
The high-yield "miscellaneous" antibacterials — each with a signature niche and warning.
Mechanism
Metronidazole → DNA damage in anaerobes/protozoa. Nitrofurantoin concentrates in urine (multiple intracellular targets). Trimethoprim ± sulfamethoxazole inhibit folate synthesis. Clindamycin (lincosamide) inhibits the 50S ribosome + suppresses toxin production.
The agents
PO/IV/PR
Anaerobes, C. diff, BV, dental; disulfiram reaction with alcohol.
oral
Lower UTI 1st-line; avoid eGFR <45 + at term (neonatal haemolysis); pulmonary fibrosis (long-term).
UTI; co-trimoxazole = PJP. Avoid trimethoprim 1st-trimester (NTD); hyperkalaemia; + methotrexate toxicity.
Necrotising fasciitis (toxin suppression), cellulitis in pen allergy; HIGHEST C. diff risk.
Adverse effects
Cautions & contraindications
Folate antagonist → NTD.
Neonatal haemolysis / ineffective.
Disulfiram reaction.
Interactions
- Metronidazole/co-trimoxazole + warfarin; trimethoprim/co-trimoxazole + methotrexate/K⁺-raising drugs
Monitoring & kinetics
Co-trimoxazole: FBC, U&E, K⁺; nitrofurantoin long-term: respiratory
Mostly oral. Each has a defining niche + warning.
Choosing it
Spectrum: Metronidazole: anaerobes + protozoa. Nitrofurantoin/trimethoprim: lower-UTI uropathogens. Co-trimoxazole: PJP. Clindamycin: Gram+/anaerobes + toxin suppression.
Source: BNF — Antibacterials